chr7-128850499-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001458.5(FLNC):​c.5398+16T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.224 in 1,598,528 control chromosomes in the GnomAD database, including 48,289 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.32 ( 10268 hom., cov: 33)
Exomes 𝑓: 0.21 ( 38021 hom. )

Consequence

FLNC
NM_001458.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.0790

Publications

8 publications found
Variant links:
Genes affected
FLNC (HGNC:3756): (filamin C) This gene encodes one of three related filamin genes, specifically gamma filamin. These filamin proteins crosslink actin filaments into orthogonal networks in cortical cytoplasm and participate in the anchoring of membrane proteins for the actin cytoskeleton. Three functional domains exist in filamin: an N-terminal filamentous actin-binding domain, a C-terminal self-association domain, and a membrane glycoprotein-binding domain. Mutations in this gene are a cause of cardiopathy. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2022]
FLNC-AS1 (HGNC:53474): (FLNC antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 7-128850499-T-C is Benign according to our data. Variant chr7-128850499-T-C is described in ClinVar as Benign. ClinVar VariationId is 258148.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.592 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FLNCNM_001458.5 linkc.5398+16T>C intron_variant Intron 32 of 47 ENST00000325888.13 NP_001449.3 Q14315-1Q59H94
FLNCNM_001127487.2 linkc.5299+16T>C intron_variant Intron 31 of 46 NP_001120959.1 Q14315-2Q59H94
FLNC-AS1NR_149055.1 linkn.316-94A>G intron_variant Intron 3 of 3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FLNCENST00000325888.13 linkc.5398+16T>C intron_variant Intron 32 of 47 1 NM_001458.5 ENSP00000327145.8 Q14315-1

Frequencies

GnomAD3 genomes
AF:
0.318
AC:
48317
AN:
151982
Hom.:
10234
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.597
Gnomad AMI
AF:
0.0877
Gnomad AMR
AF:
0.210
Gnomad ASJ
AF:
0.157
Gnomad EAS
AF:
0.467
Gnomad SAS
AF:
0.312
Gnomad FIN
AF:
0.196
Gnomad MID
AF:
0.149
Gnomad NFE
AF:
0.193
Gnomad OTH
AF:
0.282
GnomAD2 exomes
AF:
0.253
AC:
62899
AN:
248264
AF XY:
0.247
show subpopulations
Gnomad AFR exome
AF:
0.604
Gnomad AMR exome
AF:
0.220
Gnomad ASJ exome
AF:
0.152
Gnomad EAS exome
AF:
0.459
Gnomad FIN exome
AF:
0.201
Gnomad NFE exome
AF:
0.193
Gnomad OTH exome
AF:
0.230
GnomAD4 exome
AF:
0.215
AC:
310440
AN:
1446428
Hom.:
38021
Cov.:
30
AF XY:
0.216
AC XY:
155333
AN XY:
720604
show subpopulations
African (AFR)
AF:
0.607
AC:
20207
AN:
33286
American (AMR)
AF:
0.223
AC:
9973
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.147
AC:
3836
AN:
26054
East Asian (EAS)
AF:
0.461
AC:
18283
AN:
39656
South Asian (SAS)
AF:
0.288
AC:
24724
AN:
85940
European-Finnish (FIN)
AF:
0.198
AC:
10528
AN:
53170
Middle Eastern (MID)
AF:
0.155
AC:
769
AN:
4946
European-Non Finnish (NFE)
AF:
0.190
AC:
208324
AN:
1098782
Other (OTH)
AF:
0.230
AC:
13796
AN:
59884
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
13619
27238
40858
54477
68096
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7582
15164
22746
30328
37910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.318
AC:
48398
AN:
152100
Hom.:
10268
Cov.:
33
AF XY:
0.316
AC XY:
23516
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.598
AC:
24800
AN:
41484
American (AMR)
AF:
0.209
AC:
3204
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.157
AC:
545
AN:
3464
East Asian (EAS)
AF:
0.466
AC:
2403
AN:
5154
South Asian (SAS)
AF:
0.311
AC:
1498
AN:
4814
European-Finnish (FIN)
AF:
0.196
AC:
2076
AN:
10590
Middle Eastern (MID)
AF:
0.136
AC:
40
AN:
294
European-Non Finnish (NFE)
AF:
0.193
AC:
13156
AN:
67990
Other (OTH)
AF:
0.284
AC:
596
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
1505
3011
4516
6022
7527
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
448
896
1344
1792
2240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.262
Hom.:
1487
Bravo
AF:
0.332
Asia WGS
AF:
0.403
AC:
1401
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Dec 30, 2015
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 08, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Apr 04, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Myofibrillar myopathy 5;C3279722:Distal myopathy with posterior leg and anterior hand involvement;C4310749:Hypertrophic cardiomyopathy 26;CN239310:Dilated Cardiomyopathy, Dominant Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
5.8
DANN
Benign
0.62
PhyloP100
-0.079
Mutation Taster
=33/67
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13227216; hg19: chr7-128490553; COSMIC: COSV57949951; API